Market Trends– category –
-
Onalabs Secures Over 9.3 Million Euros in Funding for Sweat-Based Biosensor Technology, Accelerating Market Expansion and Clinical Validation of Sports Performance and Medical Devices
Trend Hunter Spain Overview Barcelona-based deep-tech firm Onalabs, specializing in sweat-based biosensing technology, has completed a funding round exceeding 9.3 million Euros. This capital will accelerate the industrialization and mark... -
Rising Costs of CGM and Insulin Pumps Threaten Patient Access to Home Medical Equipment in Diabetes Care: AAHomecare Warns
AAHomecare (via Facebook) America Overview Reports indicate that increasing costs for Continuous Glucose Monitoring (CGM) and insulin pumps are impacting access to diabetes care and home medical equipment. Due to largely stagnant reimbur... -
Senseonics Eversense 365 Receives FDA Approval as World’s First Year-Long Wearable CGM, Expanded Medicare Coverage to Reshape Market
Constancy Researchers America Overview Senseonics' Eversense 365 has secured FDA approval, becoming the world's first commercially available year-long implantable continuous glucose monitor (CGM). This innovation fundamentally improves p... -
Nanoparticle-Based Biosensors for Shigella Monitoring in Food Safety: Advances in High-Sensitivity and Rapid Detection Highlighted in Key Review
MDPI (Review Article) International Overview This review article outlines advancements in nanoparticle-based biosensors for rapid and highly sensitive detection of foodborne pathogen Shigella spp. It comprehensively discusses various det... -
Self-Powered Sensor Technology for Environmental Monitoring Revolutionized: Simultaneous Nanomolar Detection of pH, Heavy Metals, and Microplastics Achieved
PMC - NIH (Review Article) International Overview This review article highlights advancements in self-powered sensors for continuous real-time monitoring of pollutants and bacteria in water, soil, and air. It presents innovative solution... -
iRhythm Acquires VitalConnect for $287.5 Million, Expanding Wearable Multi-Parameter Cardiac Monitoring Platform
G-MedTech America Overview iRhythm has entered a definitive agreement to acquire VitalConnect, a leader in wearable biosensor technology and ambulatory cardiac monitoring, for approximately $287.5 million. VitalConnect's FDA-cleared plat... -
Abbott Secures CE Mark for Libre Duo Glucose-Ketone Sensor, Accelerates European Rollout of Consumer Lingo Biosensor
FreeStyle Libre Summer 2026 update Europe Overview Abbott obtained the European CE Mark in May 2026 for Libre Duo and Libre Duo 10 Day, capable of measuring both glucose and ketones for 15 days, with European market launch planned within... -
Dexcom Stelo Wins FDA Approval as First Prescription-Free OTC Continuous Glucose Monitor for Non-Insulin Users
Dexcom (via Facebook) USA Overview Dexcom's Stelo glucose biosensor system has received FDA approval as the first over-the-counter (OTC) continuous glucose monitor (CGM) for adults aged 18 and older who do not use insulin. This landmark ... -
Maravai LifeSciences Sustains Revenue Outlook in Q2, Strategically Reinforces TriLink’s mRNA, CDMO, and Specialty Chemistry Focus
TradingView USA Overview Maravai LifeSciences confirmed its Q2 revenue guidance, demonstrating resilience amidst fluctuations in large-scale CDMO projects and GMP consumables. The company reported consistent growth in smaller and mid-siz... -
EU to Introduce New 1-Year End-Use Threshold for Microplastic Exemption Under REACH Regulation by 2028
IRTS Lab EU Overview The OECD Test Guideline 318, relevant for polymeric nanomaterials, specifies dispersity, stability, and degradation testing for polymer particles ranging from 1 nm to 1 µm. This guideline is crucial for REACH complia...
